Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-07-22

Clinical Trial Update: Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS

View source ↗

Summary

A completed trial evaluating the safety and effectiveness of adding monthly dexamethasone to weekly Avonex in people with relapsing-remitting multiple sclerosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avonex (Interferon beta-1a)
  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Providence Multiple Sclerosis Center | Conditions: Relapsing-remitting Multiple Sclerosis, Clinically Isolated Syndrome | Status: COMPLETED